Fig. 1 · Structure
Documents & Downloads
4-Chloro-3-nitrobenzoic acid
Anticancer Agent Control
4-Chloro-3-nitrobenzoic acid primarily targets the synthesis of anticancer agents. While exhibiting low cytotoxicity against HepG2, A549, and HeLa cancer cells in vitro, this compound can inhibit thymidine uptake and lymphocyte growth, highlighting its potential as a biological agent. Additionally, 4-Chloro-3-nitrobenzoic acid serves as a ligand for Cu (II) complexes and is utilized in the preparation of 10H-pyrazino[2,3-b][1,4]benzothiazine derivatives, making it relevant for various chemical and pharmacological research applications.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Ligand / Binder |
| CAS Number | 96-99-1 |
| Applications | Anticancer Agent Control |
| Formula | C7H4ClNO4 |
| Molecular Weight | 201.56 |
| SMILES | O=C(O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.